NCT05700448 2026-02-05Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell LymphomaCStone PharmaceuticalsPhase 3 Not yet recruiting150 enrolled
NCT06617416 2025-03-12A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLCAkesoPhase 3 Recruiting560 enrolled
NCT06031597 2023-09-13Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction ImmunochemotherapyZhejiang Cancer HospitalPhase 3 Unknown105 enrolled